Transglutaminase 2 takes center stage as a cancer cell survival factor and therapy target
Sign Up to like & getrecommendations! Published in 2019 at "Molecular Carcinogenesis"
DOI: 10.1002/mc.22986
Abstract: Transglutaminase 2 (TG2) has emerged as a key cancer cell survival factor that drives epithelial to mesenchymal transition, angiogenesis, metastasis, inflammation, drug resistance, cancer stem cell survival and stemness, and invasion and migration. TG2 can… read more here.
Keywords: therapy target; survival factor; cell survival; cancer cell ... See more keywords